Skip to main content
HR 1480 115th Congress House Health Administrative law and regulatory procedures Canada Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Prescription drugs Trade restrictions

Safe and Affordable Drugs from Canada Act of 2017

Introduced: June 15, 2017 Introduced by: Pingree, Chellie Democratic · Maine See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2017
Referred to the Subcommittee on Health.
Mar 9, 2017
Referred to the House Committee on Energy and Commerce.
Mar 9, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Safe and Affordable Drugs from Canada Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that:

  • is dispensed by a pharmacist licensed in Canada;
  • is purchased for personal use in quantities not greater than a 90-day supply;
  • is filled using a valid prescription issued by a physician licensed to practice in the United States; and
  • has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA.

Certain medications may not be imported, including controlled substances and biological products.

The bill establishes a certification process for approving Canadian pharmacies. HHS must publish a list of approved Canadian pharmacies.

What's happening now March 10, 2017

Referred to the Subcommittee on Health.

 Related & companion bills 2
  • S 92 Related bill Safe and Affordable Drugs from Canada Act of 2017
  • S 64 Identical bill Safe and Affordable Drugs from Canada Act of 2017
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 5
All 5 Democratic 3 Republican 1
R
Joyce, David P.
Ohio · Mar 7, 2018
ROHRABACHER, DANA
· Jun 15, 2017
 D
Lofgren, Zoe
California · Jun 7, 2017
 D
Garamendi, John
California · Apr 25, 2017
 D
Cohen, Steve
Tennessee · Mar 9, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-1480/
MLA
"H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-1480/.
Bluebook (legal)
H.R. 1480, 115th Cong. (2026), https://openamerica.io/bill/115-HR-1480/.
Markdown link
[H.R. 1480: Safe and Affordable Drugs from Canada Act of 2017](https://openamerica.io/bill/115-HR-1480/)
Report a problem